SRNE
$8.15
Sorrento Therpt
$1.25
18.12%
SRNE
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  $5.79
Revenue:  N/A
Friday
Feb 5
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when SRNE reports earnings?
Beat
Meet
Miss

Where is SRNE's stock price going from here?
Up
Flat
Down
Stock chart of SRNE
Analysts
Summary of analysts' recommendations for SRNE
Score
Grade
Pivots
Resistance
$9.13
$8.72
$8.43

$8.02

Support
$7.73
$7.32
$7.03
Tweet
Growth
Description
Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesSeattle GeneticsBluebird BioQiagen N.V.Bio-TechneRepligenBioCryst Pharmaceuticals